Results 171 to 180 of about 649,932 (223)

Diagnostic image-based treatment planning for online adaptive ultra-hypofractionated prostate cancer radiotherapy with MR-Linac. [PDF]

J Appl Clin Med Phys
Xu Y, Lu N, Li Q, Men K, Zhao X, Dai J.
europepmc   +1 more source

Impact of bulk density assignment of bone on MRI-based abdominal region radiotherapy planning for MR-linac workflow. [PDF]

J Appl Clin Med Phys
Abe K, Tsuneda M, Fujita Y, Abe Y, Uno T.   +4 more
europepmc   +1 more source

Optimization of treatment workflow for 0.35T MR-Linac system. [PDF]

J Appl Clin Med Phys
Behzadipour M, Palta J, Ma T, Yuan L, Kim S, Kirby S, Torkelson L, Baker J, Koenig T, Khalifa MA, Hawranko R, Richeson D, Fields E, Weiss E, Song WY.   +14 more
europepmc   +1 more source

Gradient system characterization of a 1.5 T MR-Linac with application to 4D UTE imaging for adaptive MR-guided radiotherapy of lung cancer. [PDF]

Magn Reson Med
Goodburn R, Bruijnen T, Lecoeur B, Nair P, Ahmed M, Barnes H, Oelfke U, Wetscherek A.   +7 more
europepmc   +1 more source

Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists. [PDF]

Clin Transl Radiat Oncol
Westerhoff JM, Raaijmakers FJ, Daamen LA, de Groot-van Breugel EN, Meijers LTC, van der Voort van Zyp JRN, Verhoeff JJC, Mook S, Verkooijen HM, Intven MPW.   +9 more
europepmc   +1 more source

Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac. [PDF]

Radiat Oncol
Liu M, Liu M, Yang F, Liu Y, Wang S, Chen Y, Li J, Wang X, Orlandini LC.   +8 more
europepmc   +1 more source

Geometric and dosimetric evaluation of CTV contour adaptations by radiation therapists for adaptive prostate radiotherapy on a 0.35 T MR-Linac. [PDF]

Tech Innov Patient Support Radiat Oncol
Kalkhoven B, Hilberts MN, Verdonk MAL, Verrijssen AE, van der Toorn PG, Budiharto TCG, Bronius PFC, Geerts D, Hurkmans CW, Tetar SU, Tijssen RHN.   +10 more
europepmc   +1 more source

MR-Linac-guided stereotactic radiotherapy for CT-indiscernible intravascular renal cell carcinoma tumours. [PDF]

BJUI Compass
Shanker MD, Yu ZH, Yang J, Matin S, Campbell MT, Msaouel P, Tannir N, Prajapati S, Ding Y, Lee B, Sobremonte A, Tang C.   +11 more
europepmc   +1 more source